Clinical Trial Update: A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of discontinuing clopidogrel after drug-eluting stent implantation in non-diabetic patients; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Antiplatelet Aggregation | Phase 4 | Status: COMPLETED | Results posted: 2009-08-11